🇺🇸 FDA
Patent

US 10538749

Mutant OPAA enzymes with increased catalytic efficiency on cyclosarin

granted A61KA61K38/00

Quick answer

US patent 10538749 (Mutant OPAA enzymes with increased catalytic efficiency on cyclosarin) held by The United States of America as represented by the Secretary of the Army expires Mon Jan 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as represented by the Secretary of the Army
Grant date
Tue Jan 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K38/00